This is a paid press release. Contact the press release distributor directly with any enquiries.
Global Cognitive Computing and Artificial Intelligence Systems Market in Healthcare to Reach Significant Scale, Driven by Rising Chronic Disease Burden and Healthcare Digitalization
BCC Research LLC
Thu, 27 August 2026 at 9:35 pm GMT+5:30
4 min read
“Rising chronic disease, clinician shortages and healthcare digitalization are driving AI adoption across diagnostics, patient monitoring and drug discovery, while the deep learning segment is projected to grow at approximately 36.1% as hospitals scale image analysis and clinical decision-support platforms.”
Boston, Aug. 27, 2026 (GLOBE NEWSWIRE) — The global cognitive computing and artificial intelligence systems market in healthcare is undergoing rapid structural expansion, powered by accelerating demand for AI-enabled diagnostics, clinical decision support, and scalable patient monitoring solutions. BCC Research’s newly published report, Global Cognitive Computing and Artificial Intelligence Systems Market in Healthcare, provides comprehensive market sizing, segmentation analysis, and competitive intelligence across the forecast period.
• Market expansion is driven by the compounding pressure of chronic disease prevalence and digitalization. Rising incidences of diabetes, cancer, and cardiovascular conditions are generating sustained demand for AI-powered clinical decision support and diagnostic analytics, while deep learning — leveraging multilayer neural networks for image-based disease detection and precision diagnostics — is forecast to grow at a CAGR of approximately 36.1% over the forecast period, underscoring the pace of technological adoption.• North America holds the largest regional share at 27.4%, with Europe tied at 27.4% in 2024. North America’s position reflects mature healthcare IT infrastructure, strong venture and institutional investment in health AI, and broad enterprise adoption by integrated health systems. Europe’s near-equal share is supported by government-mandated digital health programs including the NHS digital transformation in the U.K. and Germany’s Digital Healthcare Act (DVG).• Imaging workload growth and a global shortage of skilled radiologists and pathologists are accelerating AI platform adoption. Hospitals and diagnostic centers facing unsustainable read volumes are turning to AI-enabled diagnostic platforms to improve throughput, reduce error rates, and extend specialist capacity — creating durable, recurring demand across both developed and emerging markets.• Pharmaceutical and biotechnology companies are materially increasing AI investment to compress drug discovery timelines. AI-driven analytics platforms are being deployed to improve compound screening, optimize clinical trial design, and reduce time-to-market — drawing significant R&D capital into the broader cognitive computing ecosystem and expanding the total addressable market beyond clinical settings.• A cluster of emerging technologies is reshaping the competitive frontier. Generative AI platforms such as Tempus One and AWS HealthScribe are entering radiology reporting and EHR integration workflows. Large language models including Med-PaLM 2 and MedLM are advancing clinical reasoning capabilities. GPU-accelerated genomics tools such as NVIDIA Parabricks, edge AI infrastructure for point-of-care inference, and AI-driven digital pathology platforms including PathAI AISight Dx for precision oncology are collectively expanding the solution landscape.• The competitive landscape is highly fragmented across technology hyperscalers, medical device incumbents, and pure-play AI specialists. Key participants include Alphabet Inc. (Google Inc.), Microsoft, IBM Corp., NVIDIA Corp., Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Amazon Web Services Inc., Oracle, Intel Corp., Medtronic, Tempus, Viz.ai Inc., PathAI Inc., and Datavant.
